Open original FDA record ↗Recall record
- FDA identifier
- Z-0860-2021
- Company in FDA record
- Medtronic Neuromodulation
- FDA record creation date
- Jan 14, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A710 Intellis Clinician Application has a software issue that can result in the inability to program the Intellis implantable neurostimulation device.
Source facts
- Action
- Medtronic notified the first consignee by letter on 11/12/2020 with a confirmation of their complaint and request to perform a correction to the device which put the device in a factory-reset state and restore functionality to allow programming and continued therapy. On 17 Dec 2020, Medtronic will begin issuing an Urgent Medical Device Correction notification to physicians regarding this validation error and providing instructions on the impact and appropriate mitigating actions if this issue presents.
- Initiated
- 2020-11-12
- Root cause
- Software design (manufacturing process)
- Distribution
- Worldwide distribution - US Nationwide distribution and the countries of Canada, Latin America, Asia Pacific, Japan, China, and European regions.
- Recall number
- Z-0860-2021
- Recall status
- Open, Classified
- CDRH record ID
- 184732
- FDA record created
- 2021-01-14
- Recall event number
- 86872